Rhenman & Partners Asset Management Ab Portfolio Holdings

Rhenman & Partners Asset Management Ab

  • $766 Million
  • Q2 2025

Rhenman & Partners Asset Management Ab has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $766 Million distributed in 90 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $45.1M, Boston Scientific Corp with a value of $31.8M, Vertex Pharmaceuticals Inc with a value of $27.4M, Glaukos Corp with a value of $24.3M, and Intuitive Surgical Inc with a value of $24.1M.

Examining the 13F form we can see an decrease of $74.4M in the current position value, from $840M to 766M.

Rhenman & Partners Asset Management Ab is based out at Stockholm, V7

Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.

Portfolio value $766 Million
Healthcare: $766 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 90
  • Current Value $766 Million
  • Prior Value $840 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 11 stocks
  • Additional Purchases 29 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 37 stocks
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email